A STAT Investigation Katie Palmer STAT Plus: Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future
First Opinion Howard M. Fillit STAT Plus: It’s time to move past Aduhelm and focus on a broader Alzheimer’s drug pipeline
Health Helen Branswell and Andrew Joseph ‘Testing bottleneck’ for monkeypox puts hope of containment at risk, experts warn
First Opinion Elliott J. Millenson Containing Covid-19 requires rapid tests that are highly sensitive to infections. Why is the FDA asking for something different?
Health Elizabeth Cooney Predicting preeclampsia from a blood test holds promise for pregnancy complications
First Opinion Robert Truog New guidelines on severe brain injury complicate already difficult decisions
Health Jeff Allen and Lisa Lacasse Better lab test standards can ensure precision medicine is truly precise
Business Jonathan Wosen STAT Plus: Illumina wins case against FTC in bid to hold onto early cancer detection company Grail
First Opinion Robert B. Darnell PCR testing can help clarify confusion over Covid-19 rebound and isolation
Hospitals Tara Bannow STAT Plus: Justice Department says sweeping lab test fraud in Texas involved dozens of doctors and front companies
Biotech Jonathan Wosen STAT Plus: ‘No real clear path’: Insurance coverage for cutting-edge diagnostics remains a major challenge for personalized medicine
Biotech Jonathan Wosen STAT Plus: With milestones on the horizon, Guardant Health CEOs lay out their vision for cancer detection
Politics Nicholas Florko STAT Plus: FDA asks Congress for more power to regulate certain diagnostic tests, including prenatal screenings
First Opinion Yonatan Adiri Antigen testing has some serious problems. Done right, it could reshape the future of health care
First Opinion Jeff Fischer Uncorking today’s Covid-19 supply chain to meet the challenges of future pandemics
First Opinion H. Gilbert Welch and Barnett Kramer The crazy confluence of Congress, liquid biopsies, Medicare, and health inequities
Health Tech Katie Palmer STAT Plus: As surges drive Covid-19 testing, companies eye an on-ramp for new markets
Health Andrew Joseph, Helen Branswell, Nicholas Florko and Lev Facher 13 big questions about Biden’s response to Omicron, as Congress prepares to grill Fauci, Walensky, and other top officials
First Opinion Atul Grover and Heather Pierce As vaccination efforts falter, the U.S. must get serious about Covid-19 testing and reporting
Health Lev Facher Covid antivirals could be pandemic game-changers. But Americans might struggle to access them
First Opinion Amy Lauren Fairchild and Samuel S. Malloy Make Covid-19 testing an empowering choice rather than a draconian punishment
First Opinion Glenda V. Roberts Understanding my racial heritage — thanks, Ancestry.com — could have gotten me a kidney transplant earlier
Health Nicholas St. Fleur and Eric Boodman STAT Plus: STAT+ Conversation: Pain and Promise: Examining a fibromyalgia blood test
Health Tech Kate Sheridan STAT Plus: Illumina will launch Grail’s cancer detection test in Africa and Asia — but doesn’t know when
Health Tech Maddie Bender STAT Plus: Could wearable tech — and AI — change how we diagnose infants with conditions like cerebral palsy?
A STAT Investigation Eric Boodman Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?